0 NASDAQ Companies - March 4, 2019SELLAS Life Sciences Announces Presentation of Final Data Analysis from Phase 2b Study of Nelipepimut-S Plus Trastuzumab at the 2019 ASCO-SITC Clinical Immuno-Oncology MeetingRead More
0 NASDAQ Companies - March 4, 2019PhaseBio Appoints Richard A. van den Broek to Board of DirectorsRead More
0 NASDAQ Companies - March 4, 2019Celsion Announces GEN-1 Data Presentation at ASCO-SITC Clinical Immuno-Oncology SymposiumRead More
0 NASDAQ Companies - March 4, 2019Albireo to Present at Cowen and Company 39th Annual Health Care ConferenceRead More
0 TSX Venture News - March 4, 2019GTEC Holdings Announces Alberta Craft Facility Completes First Harvest of the Year and Now Operating in Full ProductionRead More
0 TSX Venture News - March 4, 2019Electric Metals to Conduct Metallurgical Testing to Determine Amenability to HPAL ProcessingRead More
0 TSX Venture News - March 4, 2019Imperial Mining Commences Crater Lake Scandium Project Drilling Program, Northeastern QuébecRead More
0 TSX Venture News - March 4, 2019Radisson releases a presentation summarizing the 3D litho-structural reinterpretation of the O’Brien gold projectRead More
0 TSX Venture News - March 4, 2019Gold Rush Cariboo Provides 2018 Operations Update, 2019 Action Plan and Notice of Warrant AmendmentRead More
0 NASDAQ Companies - March 4, 2019IES Holdings Announces Appointment of Gary Matthews as Chief Executive OfficerRead More
